ClinicalTrials.gg
CompletedNCT04788836BrainFoodUpdated Aug 5, 2026

How Altered Gut-Brain-Axis Influences Food Choices: Part 2 (BrainFood)

An observational study in Food Preferences and Obesity, sponsored by Lia Bally. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Lia Bally · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
61
Ages
18 Years and older
Sex
All
01

Study summary

Obesity is currently one of the most substantial health burdens. Due to the production of marked and sustained weight loss, bariatric surgery is an increasingly used therapeutic modality to combat obesity and its comorbidities. Surgical rearrangement of the gastrointestinal tract remarkably alters metabolism and hormones acting on neurological and hypothalamic signalling, involved in food decision-making and eating behaviour. In this context, many patients who underwent bariatric surgery self-report changes in appetite, satiety and food preferences. Furthermore, new gut hormone-based (e.g. GLP-1 receptor agonist or GLP-1-RA) pharmacotherapies which mimic the effect of bariatric surgery show impressive efficacy on weight reduction by modulation of food behaviour. However, the mechanisms of such functional changes, and how they relate to food decision-making and food purchase behaviour remain unknown.

In Part 2 of the BrainFood-project, the investigators propose a novel approach using digital receipts from loyalty card to unravel the effect of obesity treatments (surgical and non-surgical) on eating and food purchase behaviour in daily life.

Read the detailed description

The overall aim of this project is to elucidate the changes in food behaviour among obese adults undergoing obesity treatments.

The main objective is to observe the effect of obesity treatments on food purchase behaviour using digital receipts from grocery shopping. The investigators hypothesize that bariatric surgery leads to changes in food purchase behaviour in obese adults.

The further objective is to compare food purchase behaviour between obese adults against values of an existing reference population, and to assess whether these differences tend to be reduced after the start of the treatment among obese participants.

02

Conditions studied

  • Food Preferences
  • Obesity

Keywords

  • Bariatric surgery
  • Food preferences
  • Food behaviour
  • Digital receipts
  • Grocery Shopping
  • Obesity treatment
  • GLP-1 receptor agonist
03

In context

Food Preferences

155 studies on the registry are indexed under Food Preferences; 19 are open to participants now.

This study's enrollment of 61 is below the median of 80 across 34 observational studies indexed under Food Preferences.

Browse Food Preferences studies →

Lead sponsor

Lia Bally is the lead sponsor of 15 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A minimum of 60 (up to a maximum of 150) overweight/obese adults planned for or who started surgical or non-surgical obesity treatment within the past 6 months will be recruited for this study. Participants will be recruited by referral from our outpatient endocrine clinic and collaborating Centres of Excellence for Metabolic Surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female and male subjects aged 18 years or older
  • Proficient in German (including written)
  • ≥30kg/m2 or BMI≥28kg/m2 with adiposity-related comorbidities (prediabetes, type 2 diabetes mellitus, hypertension, dyslipidemia)
  • Referred for obesity treatment or who started obesity treatment within 6 months (surgical or non-surgical)
  • Primary grocery shopping at the Swiss biggest grocery retailers (Coop, Migros), and regularly using a loyalty card (Cumulus and/or Supercard)

Exclusion criteria

Exclusion Criteria:

  • Incapacity to give
  • Primary shopping in other food retailers (e.g. Aldi, Lidl, outside of Switzerland, etc.)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
61 participants (actual)
Patient registry
No

Groups and cohorts

  • Obesity treatment Group

    60 (minimum) to 150 (maximum) overweight/obese adults referred for or who started obesity (surgical or non-surgical) treatment within 6 months

    Other: Questionnaire (Survey and Food Frequency Questionnaire (FFQ)) · Other: Collection of digital receipts from grocery shopping

  • Control Group

    Comparison of food purchase behaviour with control subjects will be performed using an already existing cohort from a previous study. This does not required recruiting control subjects.

Interventions

  • OtherQuestionnaire (Survey and Food Frequency Questionnaire (FFQ))

    Each participant will be asked to fill a web-based questionnaire that captures sociodemographic, lifestyle, physical and mental health information (Survey) and dietary intake patterns (FFQ). This will be done pre-treatment (only for those included pre-treatment), 6 months after the start of obesity treatment, 1 year after the start of the treatment and then yearly until 5 year after the start of the treatment.

  • OtherCollection of digital receipts from grocery shopping

    Participants will create their BitsaboutMe-account (GDPR-compliant data sharing platform from Bern, Switzerland) with the help of study team members. Data from digital receipts will be obtained from Migros Cumulus and Coop Supercard via their BitsaboutMe-account. The data collection allow retrospective digital receipts collection for up to 2 years and automatically continuous collection during study duration. GDPR: General Data Protection Regulation

06

What researchers measure

Primary outcomes

  1. Changes in food purchase behaviour on the basis of the Healthy Trolley Index (HETI)

    Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of the HETI, an objective and validated, nutrient-based, healthy shopping scoring system.

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  2. Changes in food purchase behaviour on the basis of the Grocery Purchase Quality Index (GPQI)

    Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of the GPQI, an objective and validated, nutrient-based, healthy shopping scoring system.

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  3. Changes in food purchase behaviour on the basis of food groups

    Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of food groups like vegetables, wholegrain, fruits, sweets and meats.

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  4. Changes in food purchase behaviour on the basis of nutrition facts

    Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of nutrition facts like energy (kcal), carbohydrates, sugars, added sugars, protein, fat, saturated fat, dietary fibre and salt.

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  5. Changes in food purchase behaviour on the basis of the Nutri-Score

    Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of the Nutri-Score, representing the nutritional quality of products. The Nutri-Score is based on a discrete continuous scale from -15 (most healthy) to 40 (least healthy). The score is then transcribed into five colour categories (A-E, ranging from bright green (most healthy) to red (least healthy)).

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  6. Food purchase behaviour on the basis of the Healthy Trolley Index (HETI)

    HETI will be compared between obesity treatment group and control group

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  7. Food purchase behaviour on the basis of the Grocery Purchase Quality Index (GPQI)

    GPQI will be compared between obesity treatment group and control group

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  8. Food purchase behaviour on the basis of food groups

    Food groups will be compared between obesity treatment group and control group

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  9. Food purchase behaviour on the basis of nutrition facts

    Nutrition facts will be compared between obesity treatment group and control group

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  10. Food purchase behaviour on the basis of the Nutri-Score

    Nutri-Score will be compared between obesity treatment group and control group

    Time frame: Pre-treatment until 5 years after start of obesity treatment

Other outcomes

  1. Correlation between food purchase patterns (i.e. HETI, GPQI, food groups, nutrition facts, Nutri-Score) and self-perceived quality of life

    Quality of life will be assessed using on a scale from 1 (very bad) to 5 (very good)

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  2. Changes in energy intake

    Energy intake in kilocalories (kcal)/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  3. Changes in daily carbohydrate intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  4. Changes in daily sugar intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  5. Changes in daily fibre intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  6. Changes in daily protein intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  7. Changes in daily fat intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  8. Changes in daily saturated fat intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  9. Changes in daily sodium intake

    Dietary intake in milligram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  10. Changes in daily vegetable intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  11. Changes in daily wholegrain intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  12. Changes in daily fruit intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  13. Changes in daily dessert intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

  14. Changes in daily meat intake

    Dietary intake in gram/day based on Food Frequency Questionnaire

    Time frame: Pre-treatment until 5 years after start of obesity treatment

07

Study locations

1 site
  • Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital
    Bern, 3010, Switzerland
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2021 to primary completion in Dec 2025, 49 months.

Of 13 observational studies under Food Preferences, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's 49 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 18, 2021
First posted
Mar 9, 2021
StartActual
Nov 1, 2021
Primary completionActual
Dec 31, 2025
CompletionActual
Dec 31, 2025
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04788836
Lead sponsor
Lia Bally
Collaborators
ETH Zurich
Responsible party
Lia Bally (Professor, Insel Gruppe AG, University Hospital Bern) — Sponsor-investigator
First posted
Mar 9, 2021
Start date
Nov 1, 2021
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025
Last update
Aug 5, 2026

Study contacts

Lia Bally, MD, PhD
principal investigator · University Hospital Bern & University of Bern

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion